Simultaneously, the prevalence of foodborne illnesses in the North American region presents substantial health challenges, as per CDC estimates. Shockingly, 1 in 6 Americans falls ill from contaminated food or beverages annually, leading to a staggering 3,000 deaths. The financial ramifications, quantified by the U.S. Department of Agriculture (USDA) at over USD 15.6 billion each year, underscore the magnitude of this issue.
In navigating this complex landscape, the market emerges as a crucial component in addressing the aftermath of foodborne illnesses. Recognized as a supportive measure, IV hydration therapy plays a pivotal role in managing dehydration, a common consequence associated with these illnesses. With its capability for efficient and swift fluid replenishment, intravenous hydration therapy becomes an invaluable asset within the healthcare response framework, actively contributing to mitigating the impact of foodborne illnesses on the well-being of individuals.
North America IV Hydration Therapy Market Report Highlights
- The North America IV hydration therapy industry in the healthcare industry was estimated at USD 1.15 billion in 2023 and is expected to reach USD 1.96 billion in 2030
- U.S. held the largest market, with a revenue share of 86.8% in 2023. The region's advanced healthcare infrastructure, increasing awareness about disease management, and a growing aging population contribute to the market's dominance
- Based on type, the energy boosters segment dominated the North America intravenous hydration therapy industry with a revenue share of 28.6% in 2023. The growth is propelled due to energy IV drip packets adoption. The drip provides energy by infusing the body with a specifically prepared blend of electrolytes, vitamins, fluids, and antioxidants to battle sensations of exhaustion & low energy
- Based on age, the 18-60 segment dominated the industry with a revenue share of 53.2% in 2023. The segment's dominance is due to this age group's increasing adoption of IV hydration therapy for various conditions
- Based on gender, the women segment dominated the market with a revenue share of 52.7% in 2023, propelled by the increasing adoption of IV therapies in skincare & beautification and for overall wellness by women
- Based on end-use, the hospitals & clinics segment dominated the market and accounted for a revenue share of 41.6% in 2023. This is attributed to the fact that most infusion therapies are carried out in hospitals and clinics for treatment of a wide variety of conditions
Table of Contents
Companies Mentioned
- Drip Hydration
- DriPros IV Hydration Wellness
- wHydrate
- Renew Ketamine & Wellness Center
- R2 Medical Clinic
- AliveDrip
- Hydrate IV
- Hydration Room
Methodology
LOADING...
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 126 |
Published | December 2023 |
Forecast Period | 2023 - 2030 |
Estimated Market Value ( USD | $ 1.15 Billion |
Forecasted Market Value ( USD | $ 1.96 Billion |
Compound Annual Growth Rate | 8.1% |
Regions Covered | North America |
No. of Companies Mentioned | 8 |